Blood Test

Early Stage Support

For pharmaceutical startups and early development companies that typically have limited or no in-house regulatory support, WR can address the special needs by serving as the integral regulatory wing. With WR’s regional partners and their combined expertise, we can address the clients’ global needs while retaining an integrated approach to development and strategy. 

In addition to providing US Agent services and strategic regulatory support,

we can help address the following questions for your specific development project:

  • Is there any benefit to filing FDA submissions or meeting with the FDA?

  • What are the activities and timelines for FDA submissions and meetings with the FDA and how does this integrate with our other development activities?

  • How should we integrate FDA regulatory activities with EMA or Health Canada?

  • What is the value proposition for our investors and potential investors in having US regulatory activity?